Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Research

Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue

Peng Su1, Qinghui Zhang1* and Qifeng Yang2*

Author Affiliations

1 Department of Pathology, Qilu Hospital, Shandong University School of Medicine, Ji'nan, China

2 Department of Breast Surgery, Qilu Hospital, Shandong University School of Medicine, Ji'nan, China

For all author emails, please log on.

Diagnostic Pathology 2010, 5:38  doi:10.1186/1746-1596-5-38

Published: 18 June 2010

Abstract

Background

Metadherin (MTDH) has been reported to be associated with cancer progression in various types of human cancers including breast cancer. Whether MTDH contributes to carcinogenesis of breast cancer is still unknown. In the present study, we investigated the expression of MTDH in normal, UDH (usual ductal hyperplasia), ADH (atypical ductal hyperplasia), DCIS (ductal carcinoma in situ) and invasive cancer to explore the possible role of MTDH for breast cancer carcinogenesis.

Methods

Immunohistochemistry was employed on paraffin sections of surgical removed breast samples.

Results

The immunohistochemical results showed almost no staining in normal tissue, moderate staining in ADH and UDH, intense MTDH stains in DCIS and cancer. Statistical analysis demonstrated significant different MTDH expression between proliferative and cancerous breast lesions (p < 0.001). MTDH was positively correlated with the histological differentiation of DCIS (p = 0.028). In breast cancer, statistical analysis revealed a significant correlation between MTDH expression with patients' age (p = 0.042), ER status (p = 0.018) and p53 status (p = 0.001). We also examined the effect of MTDH on cell proliferation in DCIS and cancer, and we found that MTDH overexpression was significantly correlated with high Ki67 index (p = 0.008 and p = 0.036, respectively).

Conclusions

MTDH overexpression could be identified in proliferative breast lesions and may contribute to breast cancer progression.